14 research outputs found

    Schematic summary of the study design showing the species, the numbers and the physiological status of the study animals.

    No full text
    <p>The study was carried out in three sites (Kabete, Kiboko and Ngong)—all government farms with similar farm management conditions. We used 404 animals in the study, including 85 cattle, 168 sheep, and 151 goats. Of these, 194 were vaccinated with RVF Clone 13 vaccine whereas 210 were injected with placebo. The study animals were divided into 3 groups; Group A included non-pregnant animals, Group B included animal in 1<sup>st</sup> half of the pregnancy, and Group C animals in 2<sup>nd</sup> half of pregnancy.</p

    Administrative Law -- Power of Board of Education to Abolish Fraternities

    No full text
    <p>Left panel (bottom) shows proportion of cattle with IgG antibodies following vaccination 14 to 366 days post-vaccination. The right panel (bottom) shows proportion of cattle that produced anti-RVF IgM antibodies over the 1 year period. The top panel on the left and right are the placebo-treated animals.</p

    Map of Kenya showing selected Rift Valley Fever (RVF) high-risk counties in grey.

    No full text
    <p>A high-risk county was based on ecological and climatic factors associated with previous RVF outbreaks in Kenya, as defined by Munyua et al. [<a href="http://www.plosntds.org/article/info:doi/10.1371/journal.pntd.0006353#pntd.0006353.ref019" target="_blank">19</a>]. The high-risk counties were selected for participation in the enhanced surveillance for RVF.</p
    corecore